In a patient with chronic permanent atrial fibrillation who currently has a VVI leadless pacemaker and is experiencing dizziness, is it appropriate to upgrade to a dual‑chamber pacemaker?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

You Are Correct—Upgrading to Dual-Chamber Pacing is Inappropriate in Permanent Atrial Fibrillation

Dual-chamber pacing or single-chamber atrial pacing should not be used in patients with permanent or longstanding persistent atrial fibrillation in whom efforts to restore or maintain sinus rhythm are not planned 1. This is a Class III recommendation (meaning it should not be done) with Level of Evidence C.

Why This is Contraindicated

The guideline evidence is unequivocal across multiple consensus statements:

  • For AV block with permanent AF: "Dual-chamber pacing should not be used in patients with AV block in permanent or longstanding persistent AF in whom efforts to restore or maintain sinus rhythm are not planned" 1

  • For any indication with permanent AF: The 2019 ACC/AHA/HRS guidelines explicitly state that "in patients with permanent or persistent AF in whom a rhythm control strategy is not planned, implantation of an atrial lead should not be performed" 2

The Clinical Reasoning

In permanent atrial fibrillation:

  1. No atrial mechanical function exists to provide AV synchrony—the primary benefit of dual-chamber pacing is lost
  2. The atrial lead provides no useful information for rate control or arrhythmia discrimination
  3. Increased procedural risks without benefit: Dual-chamber systems have a 3.09-fold higher complication rate compared to single-chamber devices within 2 months of implant 3
  4. Long-term complications increase with additional leads, including higher rates of lead dislodgement, infection risk, and need for future extractions 4

What to Do Instead

For this patient with chronic permanent AF, dizziness, and a VVI leadless pacemaker:

  • Keep the single-chamber ventricular pacing system (VVI or VVIR mode)
  • Investigate the dizziness through other means:
    • Check pacing percentage and adequacy of rate response
    • Evaluate for pacemaker syndrome (though less common with VVI in permanent AF)
    • Consider rate-adaptive programming (VVIR) if chronotropic incompetence is contributing
    • Rule out non-pacing causes of dizziness

Important Caveat

The only exception mentioned in guidelines: If the patient already has an existing dual-chamber system and subsequently develops persistent AF, it may be reasonable to use another dual-chamber device at generator change (rather than capping the atrial lead) to allow future rhythm control attempts and because of sparse safety data on MRI with abandoned leads 3. However, this does not apply to upgrading from single-chamber to dual-chamber.

Recent Leadless Technology Context

While recent studies show technical feasibility of upgrading leadless pacemakers from single to dual-chamber 5, 6, these were performed in patients with sinus node dysfunction or evolving conduction disease—not permanent AF. The technical capability to upgrade does not change the fundamental contraindication in permanent AF.

Related Questions

When is a permanent (internal) pacemaker the best treatment option for a patient with atrial fibrillation?
What is the best rate‑control treatment for a 55‑year‑old healthy male incidentally found to have atrial fibrillation with a heart rate of 110 beats per minute and blood pressure of 110/70 mmHg?
In a 57-year-old man three days after coronary artery bypass grafting who presents with palpitations and an irregularly irregular tachycardia, what ECG finding is expected?
What are the anesthesia considerations for an elderly patient (>65 years) undergoing atrial fibrillation (AF) ablation?
An 88-year-old male with chronic atrial fibrillation presents with increased fatigue; his electrocardiogram shows atrial fibrillation with a controlled ventricular rate and echocardiogram demonstrates atrial mechanical systole. What is the appropriate outpatient treatment plan?
Can Prozac (fluoxetine) tablets produce different effects or side effects than Prozac (fluoxetine) capsules in a patient who has been experiencing side effects since starting the medication?
What prophylactic anticoagulants are recommended for an adult patient with systemic lupus erythematosus and active lupus nephritis presenting with proteinuria?
How should I evaluate and manage a 33-year-old woman with no comorbidities who experiences daily episodes of hypotension (80/60 mmHg) despite a baseline blood pressure of 120/80 mmHg?
Is Hansen disease (leprosy) contagious while the patient is receiving multidrug therapy?
What are the recommended treatment strategies for adults with autism, including behavioral interventions and pharmacologic options for irritability, aggression, self‑injurious behavior, anxiety, depression, ADHD, and sleep disturbances?
What are the possible causes of cold hands and feet and how should they be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.